Risk Management in Drug-Device Combination Product Development.

Area of Science:

• Biotechnology and Pharmaceutical Sciences
• Medical Device Engineering

Background:

• Recent decades show a significant rise in combination products, driven by advancements in drug/biologic therapies and medical device technology.
• The global market for combination products is maturing, marked by three key trends: increased use of medical devices for drug delivery, growing product complexity, and heightened focus on user experience and risk.
• These products integrate drug and device components, presenting unique development and regulatory challenges.

Purpose of the Study:

• To analyze the key trends shaping the combination product market.
• To highlight the importance of integrated risk management in combination product development.
• To underscore the benefits of robust risk management for regulatory alignment and predictable outcomes.

Main Methods:

• Literature review of recent innovations and market trends in combination products.
• Analysis of the impact of technological developments on product design and delivery.
• Examination of regulatory strategies and risk management frameworks for combination products.

Main Results:

• Combination products are increasingly adopted, with a notable trend towards sophisticated drug delivery devices.
• Product complexity is rising, necessitating advanced development and manufacturing approaches.
• There is a growing emphasis on product experience and comprehensive risk assessment throughout the product lifecycle.

Conclusions:

• Integrated combination product risk management is essential for effective product development and manufacturing.
• Adopting a unified risk management strategy facilitates smoother regulatory pathways and more predictable market outcomes.
• Proactive risk management is crucial for navigating the complexities of the evolving combination product landscape.